Ingersoll Rand (IR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Achieved record Q3 2024 orders of $1,799M (up 10%) and revenues of $1,861M (up 7%) year-over-year, with over 200 basis points of adjusted EBITDA margin expansion and 9% adjusted EPS growth, despite challenging macro conditions.
Free cash flow margin reached 20% ($374M), and the company remains on track for double-digit adjusted EPS growth and strong free cash flow for 2024.
Closed 15 M&A transactions year-to-date, exceeding annual inorganic revenue targets, with 10 more deals under LOI, mainly bolt-ons, and record annualized inorganic growth in 2024.
Major acquisitions, including ILC Dover, expanded the Precision and Science Technologies segment and contributed to revenue and profit growth.
Divested asbestos-related liabilities, resulting in a $58.8 million pre-tax loss and removal of all related obligations from the balance sheet.
Financial highlights
Q3 2024 revenue: $1,861M, up 7% year-over-year; orders: $1,799M, up 10% year-over-year; gross margin improved by 130 bps to 43.8%.
Adjusted EBITDA was $533M (28.6% margin), up 15% year-over-year; adjusted EPS was $0.84, up 9% year-over-year; net income was $222M.
Free cash flow for Q3 was $374M (20% margin); operating cash flow was $404M; capex was $30M.
Total liquidity at $4.0B, with $1.4B cash on hand and $2.6B revolving credit facility; leverage at 1.7x, up 0.8x year-over-year due to ILC Dover acquisition.
Book-to-bill ratio at 0.97 for Q3; expected to be approximately 1 for full year.
Outlook and guidance
Full-year 2024 revenue guidance revised to $7,195M–$7,330M (5–7% growth); adjusted EPS guidance narrowed to $3.28–$3.34 (up 11–13% year-over-year).
Organic revenue growth guidance lowered to (2)%–0% for both total company and segments, due to order shipment timing.
Adjusted EBITDA guidance for 2024 is $2,010M–$2,040M (up ~13% year-over-year at midpoint); M&A expected to contribute $455M in 2024.
No changes to guidance on interest expense, tax rate, CapEx, or free cash flow conversion.
Sufficient liquidity is anticipated to fund obligations, working capital, and capital spending.
Latest events from Ingersoll Rand
- Recurring revenue and disciplined M&A drive growth, with strong margins and innovation focus.IR
Citi's Global Industrial Tech & Mobility Conference 202619 Feb 2026 - Recurring revenue surges and prudent growth drive strong margins and targeted M&A focus.IR
Barclays 43rd Annual Industrial Select Conference18 Feb 2026 - Strong 2025 growth, robust M&A, and steady 2026 outlook despite global challenges.IR
Q4 202513 Feb 2026 - Record Q2 results and raised 2024 guidance, driven by margin gains, M&A, and strong execution.IR
Q2 20242 Feb 2026 - Demand generation, digitalization, and M&A drive growth as legacy risks are eliminated.IR
Wells Fargo 2024 Industrials Conference1 Feb 2026 - Stable growth, active M&A, and expanding recurring revenue drive margin improvement.IR
Jefferies Global Industrial Conference 202422 Jan 2026 - Disciplined M&A, digitalization, and sustainability drive growth and margin expansion.IR
Morgan Stanley‘s 12th Annual Laguna Conference20 Jan 2026 - Disciplined M&A and life science expansion drive robust growth, margins, and value creation.IR
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026 - ILC Dover boosts life sciences, recurring revenue accelerates, and margins remain robust.IR
Goldman Sachs Industrials & Materials Conference11 Jan 2026